4//SEC Filing
TARGETED GENETICS CORP /WA/ 4
Accession 0001209191-05-028540
$ARMPCIK 0000921114operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 7:43 PM ET
Size
7.0 KB
Accession
0001209191-05-028540
Insider Transaction Report
Form 4
LACASSE LOUIS P
Director
Transactions
- Award
Stock Option (right to buy)
2005-05-26+25,000→ 25,000 totalExercise: $0.91Exp: 2015-05-26→ Common Stock (25,000 underlying)
Holdings
- 1,450,185(indirect: GeneChem Technologies Venture Fund L.P.)
Common Stock
Footnotes (3)
- [F1]Represents shares held by GeneChem Technologies Venture Fund L.P. ("GeneChem"). The reporting person is president of GeneChem Management, Inc., the manager of GeneChem, and thereby has power to vote the securities held by GeneChem; however, the reporting person disclaims beneficial ownership of such shares.
- [F2]Such option is 100% vested and exercisable on May 26, 2006, subject to the provision of continued service by the optionee to the issuer.
- [F3]Price is not applicable.
Documents
Issuer
TARGETED GENETICS CORP /WA/
CIK 0000921114
Entity typeoperating
IncorporatedWA
Related Parties
1- filerCIK 0000921114
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 7:43 PM ET
- Size
- 7.0 KB